Rita L. Hui

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

David J. Graham, David Campen, Rita L. Hui et al. · The Lancet · 2005 · 909 citations

Cardiovascular Disease, Medicine, Cyclo-oxygenase 2 +9

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Sylvia Adams, P. Schmid, H. S. Rugo et al. · Annals of Oncology · 2018 · 756 citations · Full text

Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure

Joan C. Lo, Felice O’Ryan, Nancy P. Gordon et al. · Journal of Oral and Maxillofacial Surgery · 2009 · 486 citations · Full text

Bone Disease, Bone Health, Osteopathy +4

Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial

Sherene Loi, Anita Giobbie‐Hurder, Andrea Gombos et al. · The Lancet Oncology · 2019 · 464 citations

Breast Oncology, Oncology, Pharmacology +8

Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189

Delvys Rodríguez‐Abreu, Steven Powell, Maximilian J. Hochmair et al. · Annals of Oncology · 2021 · 405 citations · Full text

Protocol-specified Final Analysis, Prognostic Biomarkers, Urology +9